Quick takes: Polio in 6 nations, tularemia cases in Nebraska, more H5N1 in US poultry

News brief
Topics
Avian Influenza (Bird Flu)
Polio
Tularemia
  • New polio cases were reported in six countries this week, according to the latest update from the Global Polio Eradication Initiative. Pakistan reported a case of wild poliovirus type 1 (WPV1) with onset of paralysis on May 7, bringing its WPV1 case total this year to 11. Five other countries reported circulating vaccine-derived poliovirus type 2 (cVDPV2) cases: Ethiopia (8), Yemen (3), Chad (2), Angola (1), and Niger (1).
  • Public health officials in Nebraska this week said they've received reports of three human cases of tularemia in the southwestern part of the state, a much higher number than normal. Tularemia is caused by a bacterium (Francisella tularensis) spread via tick and deer-fly bites or contact with infected animals. Symptoms include fever, headache, swollen glands, and skin ulcers at the site of the bite. "This is a concerning number of cases for this tickborne disease," Melissa Propp RN, of the Southwest Nebraska Public Health Department, said in a press release. "Only 6 cases of tularemia were reported to us during the past 10 years, so getting three cases in a month is unusual."
  • The US Department of Agriculture's Animal and Plant Health Inspection Service yesterday reported an outbreak of H5N1 avian flu at a commercial table egg pullet operation in Maricopa County, Arizona. It's the state's fourth commercial operation affected by the outbreak over the last 30 days. Since the start of the US outbreak on February 8, 2022, highly pathogenic avian influenza has been detected in 1,706 flocks in 50 states and 1 territory, affecting more than 174 million birds.

Study finds non-prescription antibiotic use high in young children in poorer countries

News brief
Topics
Antimicrobial Stewardship
Pills in hands of children
showcake / iStock

More than one third of children younger than 5 years old in low- and middle-income countries (LMICs) receive antibiotics without a prescription, researchers reported today in JAC-Antimicrobial Resistance.

In a systematic review and meta-analysis, Ethiopian researchers examined 12 observational studies that addressed antibiotic use without a prescription in children under 5 in LMICs. While the widespread use of antibiotics without a prescription in LMICs is well-documented, no prior systematic review and meta-analysis has been conducted on antibiotic use without a prescription in children under 5 in LMICs, a population that's known to commonly receive antibiotics for community infections that may be self-limiting or caused by viruses. 

The 12 cross-sectional studies had a combined sample size of 8,773 participants and were conducted in Africa (6), Asia (3), and South America (3). The pooled prevalence of antibiotic use without a prescription was 33.3% (95% confidence interval [CI], 27.4% to 39.2%), with the highest pooled estimate found among studies from Africa (39.9%; 95% CI, 35.6% to 44.1%) and lowest in studies from South America (28.6%; 95% CI, 24.2% to 33.0%). Among individual countries, the highest prevalence was in Nigeria (46.7%), and the lowest was in China (14.5%).

The analysis also found the most common sources for non-prescription antibiotics were community pharmacies, which is similar to findings from previous studies. 

Major factor in emergence, spread of AMR

Antibiotic use without a prescription is considered a major contributing factor in the emergence and spread of antimicrobial resistance (AMR), and it is among the issues that the World Health Organization (WHO) has said should be addressed by antimicrobial stewardship programs. But while stewardship programs have become well-established in developed nations, they haven't been as successfully implemented in LMICs.

The study authors say the findings imply that LMICs should"strengthen their regulatory systems, prevent childhood infections, increase healthcare accessibility, improve health insurance coverage, and enhance awareness of the public concerning the impact of antibiotic use without prescription."

"The results of this study will be crucial for the WHO, the health ministries of the respective countries, regulatory systems and other non-governmental organizations working in child health," they concluded.

This week's top reads

  1. Woman dies from brain ameba after flushing nose with RV water

    The woman had amebic meningoencephalitis, a rare, often fatal brain infection caused by the ameba Naegleria fowleri.

    Jim Wappes
    Neti pot in use

  2. US measles total nears 1,100 cases as Colorado reports airline cluster

    Some of the latest cases are tied to a large outbreak centered in West Texas, while others are linked to instances of community transmission or travel to other states or countries.

    Lisa Schnirring
    airline passengers

  3. WHO warns of rising COVID activity in 3 global regions

    The increase in activity is seen in the Western Pacific, Southeast Asia, and Eastern Mediterranean regions.

    Stephanie Soucheray

  4. Long-COVID symptoms in young kids can vary by age

    Preschool-aged children were more likely to have a dry cough and daytime tiredness or low energy.

    Stephanie Soucheray
    sick boy cough

  5. Prior COVID vaccination produces immune response against new SARS-CoV-2 strains, study finds

    Neutralizing antibodies tested 90 days after infection were greater in participants who had been vaccinated before their variant infections than in those who had been vaccine-naive.

    Stephanie Soucheray

  6. Colorado confirms 3 more infections in airport-linked measles outbreak

    Other states report more cases, including Minnesota, with two, one of which involves a child whose infection suggests community spread.

    Lisa Schnirring
    DIA

  7. HHS cancels funding for Moderna’s candidate H5 avian flu and pandemic vaccines

    Buoyed by promising clinical findings, Moderna says it will explore alternatives for late-stage development of the H5 vaccine.

    Lisa Schnirring
    syringe and vial

  8. FDA approves Moderna's new COVID-19 vaccine

    The company's "next-generation" COVID-19 vaccine, mNexspike, was approved for adults 65 and older and younger people at risk of severe disease.

    Chris Dall

  9. MAHA report on chronic disease in US kids includes fake citations, other errors

    A Trump administration report outlining the potential factors related to the rise in chronic diseases in US children cites several studies that don't exist.

    Chris Dall

  10. Long-COVID diagnoses fairly common in Medicare claims

    Beneficiaries with 4 or more COVID-19 vaccine doses had a 39% lower rate of long COVID.

    Stephanie Soucheray

Our underwriters